Hantz Financial Services Inc. Boosts Stock Holdings in Encompass Health Corporation $EHC

Hantz Financial Services Inc. boosted its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 16,653.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 76,900 shares of the company’s stock after buying an additional 76,441 shares during the quarter. Hantz Financial Services Inc.’s holdings in Encompass Health were worth $9,430,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Pinnacle Wealth Planning Services Inc. increased its holdings in shares of Encompass Health by 4.0% in the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock valued at $263,000 after acquiring an additional 99 shares during the period. Securian Asset Management Inc. increased its holdings in shares of Encompass Health by 1.3% in the 2nd quarter. Securian Asset Management Inc. now owns 7,716 shares of the company’s stock valued at $946,000 after acquiring an additional 100 shares during the period. Caitong International Asset Management Co. Ltd grew its stake in Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after purchasing an additional 115 shares during the last quarter. UMB Bank n.a. grew its stake in Encompass Health by 10.9% in the second quarter. UMB Bank n.a. now owns 1,187 shares of the company’s stock valued at $146,000 after purchasing an additional 117 shares during the last quarter. Finally, Arlington Trust Co LLC grew its stake in Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock valued at $68,000 after purchasing an additional 125 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have issued reports on EHC. Bank of America lifted their target price on Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. Barclays lifted their price objective on shares of Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research report on Thursday. UBS Group lifted their price target on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Finally, Zacks Research upgraded Encompass Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. Two research analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of $142.86.

Encompass Health Price Performance

Shares of EHC opened at $118.04 on Friday. The firm has a market capitalization of $11.89 billion, a PE ratio of 22.31, a price-to-earnings-growth ratio of 2.20 and a beta of 0.93. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.99. The company’s fifty day moving average price is $124.39 and its 200-day moving average price is $118.80.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, equities research analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, January 2nd. Encompass Health’s payout ratio is presently 14.87%.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the sale, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.00% of the stock is currently owned by corporate insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.